awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q47094091-2C72DB4F-3366-4C6A-B15A-FA9684594C35
Q47094091-2C72DB4F-3366-4C6A-B15A-FA9684594C35
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47094091-2C72DB4F-3366-4C6A-B15A-FA9684594C35
Anti-LINGO-1 has no detectable immunomodulatory effects in preclinical and phase 1 studies.
P2860
Q47094091-2C72DB4F-3366-4C6A-B15A-FA9684594C35
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47094091-2C72DB4F-3366-4C6A-B15A-FA9684594C35
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
84314d37558bc6e029b763957ce379883b9a2590
P2860
Safety and efficacy of opicinumab in acute optic neuritis (RENEW): a randomised, placebo-controlled, phase 2 trial.